ABSTRACT-Syndecan-1 (Sdc1) is considered a biomarker of injury to the endothelial glycocalyx following hemorrhagic shock, with shedding of Sdc1 deleterious. Resuscitation with fresh frozen plasma (FFP) has been correlated with restitution of pulmonary Sdc1 and reduction of lung injury, but the precise contribution of Sdc1 to FFPs protection in the lung remains unclear. Human lung endothelial cells were used to assess the time and dose-dependent effect of FFPon Sdc1 expression and the effect of Sdc1 silencing on in vitro endothelial cell permeability and actin stress fiber formation. Wild-type and Sdc1
INTRODUCTION
Trauma is the third leading cause of death across all age groups (1, 2) . Of these deaths, hemorrhage remains the number one cause of early trauma deaths, though reductions in early mortality have occurred from modern resuscitation strategies employing the early and empiric use of plasma (3) (4) (5) . This decrease in mortality from plasma-based resuscitative strategies appears to extend beyond its ability to correct trauma-induced coagulopathy and provide hemorrhage control and is thought to involve repair of a dysfunctional endothelium that follows trauma and hemorrhage. This ''endotheliopathy of trauma'' is a systemic response by the injured endothelium resulting in abnormalities of coagulation, inflammation, and endothelial barrier integrity (6) . Clinically, this is manifested as a pro-inflammatory state along with capillary leak and subsequent tissue edema, both of which may contribute to organ dysfunction and late deaths. Therefore, restoring the endothelium and barrier integrity is integral to further reducing hemorrhagic shock-related morbidity and mortality.
We have been interested in endothelial repair by plasma which we hypothesize is due in part to restoration of the glycocalyx and syndecan-1 (Sdc1) backbone on injured endothelial cells. The endothelial glycocalyx is a complex network of soluble components that projects from the endothelial surface and consists of proteoglycans and glycoproteins. The proteoglycans provide structural support for the glycocalyx and consist of a core protein, primarily syndecan, to which the glycosaminoglycans attach. For Sdc1, heparan sulfate chains are the main glycosaminoglycans (7) . There are four members (syndecans 1-4) that comprise the syndecan family. Sdc1 has been the focus of most studies as it has become a recognized systemic marker of damage to the glycocalyx. Syndecans 2 and 4, like Sdc1, are found on endothelial cells and in the lung, though little data exists on their contribution after shock. Injury to the glycocalyx results in shedding of the Sdc1 ectodomain after a variety of shock states (8) (9) (10) . Shedding is considered deleterious as the Sdc1 ectodomain and its heparan sulfate side chains can function as danger-associated pattern molecules, contributing to sterile inflammation, immunosuppression, and autoheparinization following trauma (11) (12) (13) . Ectodomains have been detected in the blood of patients with sepsis, hemorrhagic shock, and ischemia-reperfusion injury, and in fluids from infected or injured tissues (14) . In injured patients, shedding is associated with enhanced shock, inflammation, coagulopathy, endothelial damage, and is an independent predictor of morality (15) (16) (17) . We and others have shown in the laboratory that plasma promotes endothelial restoration of Sdc1 and the glycocalyx following hemorrhagic shock (18, 19) . The specific contribution of Sdc1 to plasma's pulmonary protection, however, remains unclear. We hypothesized that loss of Sdc1 would worsen pulmonary injury and abrogate protection by plasma.
MATERIALS AND METHODS

In vitro
Cell culture-Human lung microvascular endothelial cells (HLMECs, PromoCell) were grown to confluence in supplemented endothelial basic medium-2 (EBM-2, Lonza). Prior to experiments, cells (passages 5-10) were cultured under low serum conditions (0.5% FBS) for 2 h and then incubated in EBM-2 containing 10% lactated Ringers (LR) or 10% fresh frozen plasma (FFP), as we have shown this concentration to be optimal (20) .
RNA silencing of Sdc1-Four sets of predesigned human Sdc1 smallinterference RNA (siRNA) pools and negative control siRNA (scrambled siRNA) were purchased from Dharmacon (Lafayette, Colo). The sequences were as follows: 5'-ACGCAGCUCCUGACGGCUA-3'; 5'-GUAACGA-CAAUAAACGGUA-3'; 5'-CAUCAGGCCUCAACGACCA-3'; 5'-UGG-GAAACUUGGCUCGAAU-3'. Transfections were performed with DharmaFECT 4 according to the manufacturer's instructions. Immunoblot analysis was used to assess efficacy of downregulation of the RNA.
Endothelial permeability-Transwell permeability was assessed in confluent monolayers by adding fluorescein isothiocyanate (FITC)-dextran (40 kDa) to the upper chamber. After 30 min, samples were collected from the lower chamber and the fluorescent intensity determined using a fluorimeter. The fold change in FITC-dextran fluorescence intensity over controls was calculated as we have described (21) .
Actin stress fiber staining-Cells were grown on gelatin-coated eight-well chamber slides and fixed in 4% paraformaldehyde and then permeabilized with 0.1% Triton X-100. After washing and blocking with 1% BSA, cells were incubated with 1 U/mL of Texas red-X phalloidin (Molecular Probes, ThermoFisher, Waltham, Mass) which is specific for F-actin.
In vivo
Mouse model of hemorrhagic shock-All procedures performed were approved by the University of Texas Health Science Center at Houston or Maryland School of Medicine Animal Welfare Committees. The experiments were conducted in compliance with the National Institutes of Health guidelines on the use of laboratory animals. All animals were housed at constant room temperature with a 12:12-h light-dark cycle with access to food and water ad libitum. Male wild-type (WT) littermates and syndecan-1 null (Sdc1 À/À ) mice on the C57BL/6J background were used at 8 to 10 weeks of age and weighing approximately 25 g. Our established mouse model of trauma-hemorrhagic shock was utilized (21) . Under isoflurane anesthesia, a midline laparotomy incision was made, the intestines were inspected, and then the incision was closed. The right femoral artery was cannulated for continuous hemodynamic monitoring and blood withdrawal or resuscitation. Mean arterial blood pressure was recorded via the femoral arterial line at baseline and then every 5 min during the shock period. After a 10-min period of equilibration, mice were bled to a mean arterial pressure of 35 AE 5 mm Hg which was maintained for 90 min. Shams underwent anesthesia and placement of catheters but were not subjected to laparotomy or hemorrhagic shock. Shock animals were resuscitated with either LR at 3X shed blood volume or fresh frozen plasma at 1X shed blood and compared with animals that underwent shock alone as we have described (21, 22) . Following resuscitation, lines were removed and the animals awoken to more closely mimic an awake shock model. Three hours after the end of shock, animals were sacrificed by exsanguination under isoflurane anesthesia and lungs harvested for further analysis. This time point was chosen based on our previous investigation showing pulmonary protection and partial restitution of pulmonary Sdc1 by plasma at this time point (18, 21) . For FFP, single-donor fresh frozen plasma was thawed, aliquoted, and then samples stored frozen at À208C until ready for use.
Lung permeability-Evans blue dye extravasation was used as an indicator of vascular permeability. Animals received a bolus injection of 3% Evans blue (4 mL/kg) 1 h prior to sacrifice. At sacrifice, animals were perfused via the right ventricle with 10 mL PBS to remove the intravascular dye from vessels. Lungs were harvested and then incubated in formamide for 24 h at 558C to allow for dye extraction. After centrifugation, absorbance was measured in the supernatant at 620 nm using a plate reader.
Lung histopathologic injury-Lung tissue sections were stained with hematoxylin and eosin and scored on a three-point scale for alveolar thickness, capillary congestion, and cellularity, as initially described by Hart et al. and as we have reported (18, 23) . The overall lung injury score was calculated by averaging the three parameters.
Lung inflammation-Infiltration of neutrophils was assessed by myeloperoxidase (MPO) immunofluorescence staining. Paraffin-embedded tissue was cut into 5-mm-thick sections and then incubated with MPO primary antibody (1:100 MPO mouse monoclonal antibody; Abcam, Cambridge, Mass) followed by incubation with secondary antibody (goat antimouse; AlexaFluor 568, Invitrogen, Carlsbad, Calif). Two random images were taken from each lung section with a fluorescent microscope (Nikon Eclipse Ti) at 200 magnification and quantified using ImageJ software (NIH). Results are reported as relative fluorescence units.
Pulmonary syndecan 2 and syndecan 4-As both syndecans 2 and 4 are found in endothelial cells and in the lung, lung tissues were homogenized for measurement of syndecan 2 and syndecan 4 by enzyme-linked immunosorbent assay according to manufacturer's instructions (MyBioSource, San Diego, Calif).
Data analysis
All data were analyzed by one-way analysis of variance with Bonferroni correction. P values <0.05 were considered significant. Data are expressed as mean AE SEM. In vitro data was repeated in triplicates; n ¼ at least 8/group for in vivo animal experiments.
RESULTS
In vitro
In HLMECs, FFP increased Sdc1 immunostaining in a doseresponse and time-dependent fashion (Fig. 1, A and B) . To investigate the contribution of Sdc1 to pulmonary endothelial cell permeability, siRNA was used to silence Sdc1 expression. Under basal conditions, permeability was significantly reduced by FFP compared with LR-treated cells (0.67 AE 0.15 FFP vs. 1.0 AE 0.07 LR, P < 0.05), similar to our previous findings ( Fig. 2A) (15, 19, 20) . After silencing, however, permeability was significantly increased in Sdc1 siRNA transfected cells compared with non-silenced cells (2.43 AE 0.08 si þ FFP vs. 0.67 AE 0.15 sc þ FFP, P < 0.01) and to silenced cells treated with LR (1.39 AE 0.24 si-LR, P < 0.05). Actin stress fibers are markers of endothelial disruption. Stress fiber staining was consistent with permeability results with stress fibers increased in silenced FFP-treated cells (Fig. 2B) .
In vivo
FFP lessens hemorrhagic shock-induced lung hyper-permeability in wild-type but not Sdc1 À/À mice-To confirm and expand upon on our in vitro results, wild-type and Sdc1 À/À mice were subjected to hemorrhagic shock and resuscitation with either FFP or LR. As we have previously shown, hemorrhagic shock significantly increased lung permeability compared with shams (2.46 AE 0.27 HS vs. 0.72 AE 0.07 Sham, P < 0.01), is lessened by LR (1.70 AE 0.20) but further reduced by FFP (1.00 AE 0.08) (Fig. 3) 
(21). Sdc1
À/À mice similarly had enhanced permeability after hemorrhagic shock (3.03 AE 0.31 HS vs. 0.74 AE 0.06 Sham, P < 0.01) which was also lessened by LR (2.21 AE 0.18) but with no further benefit from FFP (1.94 AE 0.16).
FFP reduces pulmonary inflammation in wild-type but not Sdc1 À/À mice-Myeloperoxidase is an indicator of neutrophil infiltration. MPO immunostaining (Fig. 4A) Impact of resuscitation on pulmonary syndecan 2 and syndecan 4-In the next set of experiments, we assessed pulmonary expression of syndecan 2 and syndecan 4, both of which are found in endothelial cells and the lung (24) , to evaluate possible compensatory increases in other members of the syndecan family. In WT and in Sdc1 À/À mice, pulmonary syndecan 2 and syndecan 4 protein expression showed syndecan 2 was reduced by shock compared with sham mice, increased by FFP compared with shock alone, but with no significant difference in expression between FFP and LR resuscitated animals (Fig. 5A) . Syndecan 4 expression in WT mice was reduced by hemorrhagic shock compared with shams, increased by FFP compared with shock alone, but again with no significant difference in expression between FFP and LR-resuscitated animals (Fig. 5B) . However, in Sdc1 À/À mice, FFP resuscitation significantly increased pulmonary syndecan-4 expression compared with LR resuscitated animals.
DISCUSSION
We demonstrated in vitro that FFP enhanced pulmonary endothelial Sdc1 expression in time-and dose-dependent manners. Importantly, expression was increased as early as 3 h, the same time that we have shown in vivo partial restoration of the endothelial glycocalyx (18) . We hypothesized that if indeed Sdc1 was the key to FFPs post-hemorrhagic shock protection to the endothelium, that the absence of Sdc1 would abrogate FFPs protection. When Sdc1 expression in pulmonary vascular endothelial cells was silenced, FFP not only lost its protection compared with LR, but monolayer permeability was actually enhanced. Consistent with this, actin stress fiber formation, a marker of endothelial disruption, was similarly increased in silenced cells exposed to FFP. The worsening of permeability in silenced endothelial cells suggests that FFP interacts with syndecan to exert its protection. In the absence of syndecan, FFP may be in direct contact with the endothelium. Yakovlev et al. (25) examined the effects of a recombinant fibrinogen fragment with proven benefit to barrier integrity in animal models of shock. In vitro (no insult) they found that fibrinogen caused internalization of VE-cadherin and loosening of cellcell junctions (25) . It is possible that FFP may be functioning by a similar mechanism, as fibrinogen is a normal component of plasma. Clinically, cell membranes are likely never completely devoid of cell surface Sdc1, as there appears to be rapid mobilization from presumably intracellular stores, though this has not been well studied (16) . Cells do attempt to maintain cell surface expression of heparan sulfate proteoglycans such as syndecan. How this is accomplished is not known. There are several studies suggesting that heparan sulfate proteoglycans can both be internalized via endocytic vesicles and can be recycled to the cell surface (26, 27) .
Our in vivo studies confirmed our in vitro results, demonstrating the key role of Sdc1 in FFPs reduction in pulmonary permeability, inflammation, and injury after hemorrhagic shock. This is important as in vitro studies were in isolated pulmonary endothelial cells but in vivo, intact lungs were used which are comprised of both immune and epithelial cells as well as endothelial cells. Other investigators have also shown that pulmonary sdc1 is important. Brauer et al. (28) reported that Sdc1 knockout increased bronchial epithelial apoptosis and enhanced bronchoaveolar lavage protein extravasation in mice during influenza infection. In another study, Sdc1 attenuated allergic lung inflammation, with null mice exhibiting exaggerated airway responsiveness (29) .
We have previously shown that plasma abrogated gut injury and inflammation after hemorrhagic shock in WT but not in Sdc1 À/À mice, similar to our current findings in the lung (22) . With an intact Sdc1backbone and endothelial glycocalyx, an important barrier between circulating leukocytes and the endothelial cell surface is established. In the absence of Sdc1, leukocyte transmigration and inflammation is enhanced. Wild-type animals demonstrated a significant increase in both systemic TNFa and ADAM-17, a protein that cleaves TNFa, which was further increased in Sdc1 À/À mice. Plasma resuscitation lessened both TNFa and ADAM-17 in WT but not in Sdc1 À/À mice, highlighting the role of Sdc1 in plasma's protection. However, the phenotypic shift to a pro-inflammatory phenotype identified in the gut of Sdc À/À mice was not present in the lung. Also, although FFP lost its protective effect in Sdc À/À mice in both the gut and the lung, differences were not as striking in the lung. This led us to hypothesize that other members of the syndecan family may be contributing to pulmonary endothelial protection after hemorrhagic shock. Both syndecan 2 and syndecan 4 are found in endothelial cells and in the lung. In wild-type mice, there was a significant increase in both pulmonary syndecan 2 and 4 after FFP compared with shock alone. There was also an increase, though not statistically significant, in both syndecans after FFP compared with LR, implying that these syndecans may be at least contributing to endothelial protection by FFP. However, in Sdc1 À/À mice, syndecan 4 was significantly increased by FFP compared with LR, implying that syndecan 4 is compensating for the loss of syndecan 1. This finding is supported by Savery et al. (30) who reported that the endothelial glycocalyx in Sdc1 À/À mice was thinner but still detectable, raising the question by these authors if other members of the syndecan family were compensating for the loss of Sdc1. Although we did not measure or visualize the glycocalxy in this study, our results are consistent with the hypothesis that syndecan 4 may be contributing to the integrity of the glycocalyx in Sdc1 À/À mice. Additionally, Voyvodic et al. (31) recently found that in pulmonary endothelial cells isolated from Sdc1 À/À mice, syndecan 4 was significantly increased compared with WT endothelial cells. We used intact lungs and while we did not demonstrate an increase at baseline or after shock between WT and null mice, we did find an increase in syndecan 4 in Sdc1 À/À lungs after FFP administration.
Taken together our results suggest a protective role for Sdc1 after shock with its expression supporting pulmonary protection and generation of a shock protective phenotype that is generated by FFP. In vitro loss of Sdc1 in pulmonary endothelial cells worsened permeability and stress fiber formation by FFP, while loss in vivo leads to equivalency between LR and FFP in restoring pulmonary injury, inflammation, and permeability after shock. Lastly, the loss of Sdc1 also leads to an increase in pulmonary syndecan 4 expression specifically after hemorrhagic shock and FFP-based resuscitation. We believe this is a compensatory mechanism in Sdc1 À/À mice; despite this response, FFPs loss of pulmonary protection further highlights the key role of Sdc1 in its protection.
